$LTRN reminding investors about BIO2026 participation tomorrow!

Lantern Pharma just posted a reminder that CEO Panna Sharma will participate in tomorrow’s BIO2026 executive roundtable hosted by Polsinelli. What caught my attention is that management is actively promoting the event instead of quietly attending. At a $50M market cap, Lantern is trying to position itself at the intersection of: Precision oncology AI-driven drug development RADR / withZeta Not suggesting news is coming. But if management believes these platforms are meaningful value drivers, BIO